Table 1 Patient characteristics
Characteristics | number of patients (n = 19) |
|---|---|
Gender | Male 18, Female 1 |
Median age (range), years | 67 (49–80) |
Histology | Squamous cell carcinoma 13 Adenocarcinoma 4 Adenosquamous cell carcinoma 1 Large cell carcinoma 1 |
Smoke history | Current 6, Former 13 |
Pack-years (range) | 45 pack-years(12.5–116) |
Performance status | PS0 1, PS1 18 |
Treatment line | 2nd line, 6 3rd line, 8 More than 4th line, 5 |
PD-1/PD-L1 antibodies | Nivolumab 18 Atezolizumab 1 |
Adverse events | Interstitial pneumonia 10 diarrhea 2 hematological toxicity 2 anaphylactic 2, eruption 1, hemoptysis 1, hypophysitis1 |
Treatment for adverse events | Steroid 14, others 5 |